Global Protein Therapeutics Market (2021 to 2026) – Industry Trends, Share, Size, Growth, Opportunity and Forecasts – Yahoo Finance

DUBLIN, Oct. 18, 2021 /PRNewswire/ -- The "Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global protein therapeutics market exhibited moderate growth during 2015-2020

Horizon Theatre Announces Return to Live and In-Person Theatre with SOUTHBOUND HALLOWEEN – Broadway World

Celebrate the Halloween season with the grand reopening of the Horizon Theatre Company with Southbound Halloween: The Spooky, The Sexy, The Scandalous - a night of hilarious, spine-tingling, and suspenseful real-life stories told live onstage in Little Five Points. The evening will also feature musical guest, The Tomb Tones playing ghoulishly good tunes.

Blessing Okagbare charged with use of two banned substances – AW – Athletics Weekly

Nigerian sprinter charged with use of Human Growth Hormone, EPO and refusal to co-operate with investigation Blessing Okagbare, who competed at the Tokyo Olympics in the womens 100m heats before being provisionally suspended, is facing fresh charges from the Athletics Integrity Unit. The AIU have charged the 32-year-old Nigerian an Olympic and world silver medallist and two-time Commonwealth champion with use of the banned substances Human Growth Hormone (HGH) and EPO, while also allegedly failing to co-operate with the investigation

NZME Limited (NZX: NZM) Half Year Results to 30 June 2021 – sharechat.co.nz – sharechat

NZME Limited has today announced its financial results for the half year ended 30 June 2021, reporting Statutory Net Profit After Tax (NPAT) of $5.6 million, up 85% on the corresponding period in 2020. NZME also announced growth in Operating Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) to $30.1 million for the half year, representing 4% growth in Operating EBITDA against the first half of 2020

Ascendis Pharma A/S Announces Second Quarter 2021 Financial Results and Business Update Conference Call on August 25 – Stockhouse

COPENHAGEN, Denmark, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to create product candidates that address unmet medical needs, today announced that the company will hold a conference call and live webcast on Wednesday, August 25, 2021 at 4:30 p.m.

Hartford Services – FXDFR DB REDEEM 15/04/2042 USD 25 (HGH) gains 0.15% in Active Trading on August 6 – Equities.com

Last Price$ Last TradeChange$ Change Percent %Open$ Prev Close$ High$ low$ 52 Week High$ 52 Week Low$ Market CapPE RatioVolumeExchange HGH - Market Data & News Today, Hartford Financial Services Group Inc. - FXDFR DB REDEEM 15/04/2042 USD 25 Incs (NYSE: HGH) stock gained $0.04, accounting for a 0.15% increase. Hartford Services - FXDFR DB REDEEM 15/04/2042 USD 25 opened at $26.41 before trading between $26.45 and $26.36 throughout Fridays session.